• | home
  • | corporate
  • | investors
  • | products
  • | clinical trials
  • | partnering
  • | contact
TSX: HBP - NYSE Amex: HBP - Frankfurt: HBP

Presentations and Podcasts >> Scientific Presentations

  • | Overview
  • | Corporate Governance
    • | Board Mandate
    • | Board Committee Charters
    • | Whistleblowing Policy
    • | Code of Conduct
  • | Investor Fact Sheet
  • | News Releases
    • | Fiscal 2012
    • | Archive
  • | Financial Statements
    • | Fiscal 2012
    • | Archive
  • | Annual Reports
  • | Regulatory Filings
  • | Analyst Coverage
  • | Presentations
    • | Corporate Presentations
    • | Scientific Presentations
  • | FAQ Investor Relations
  • | Stock Quote
  • | Shareholder Services
  • | Email Alerts
  • | Legal Disclaimer
  • | Contact IR

Scientific Presentations

If you would like to be added to the news release distribution list, please fill out the email alerts form here

Latest Scientific Presentation


June 30, 2011 Dr. Heman Chao To Present At The Fourteenth World Conference On Lung Cancer In Amsterdam On July 5th, 2011
   

 

Archive


Feb 10, 2011 Helix BioPharma Corp. Presents at the Third International Conference on Drug Discovery and Therapy in Dubai on February 10.
Feb 10, 2011 Topical Interferon Alpha-2b Poster Presentation
June 21st - June 24th, 2009 Dr. Heman Chao presents "Analytical Method Development for L-DOS47, a Novel Candidate for the Treatment of Lung Adenocarcinoma" poster at the 2009 American Association of Pharmaceutical Scientists (“AAPS”) National Biotechnology Conference                                                                             
November 19, 2008 Helix BioPharma Presents Preclinical L-DOS47 Data at the Second Conference of Lung Cancer in Warsaw Poland
 
   


  • | home
  • | site map
  • | privacy
  • | terms of use / disclaimers
  • | polski
  • | login
© Helix BioPharma Corp.